Literature DB >> 9251740

Clinical usefulness of CT in the treatment of stage I endometrial carcinoma.

A La Fianza1, E M Di Maggio, L Preda, D Coscia, S Tateo, R Campani.   

Abstract

This retrospective study was aimed at assessing Computed Tomography (CT) capabilities in identifying low- and high-risk groups of clinical stage I endometrial carcinoma patients. CT of the pelvis was performed on 125 endometrial carcinoma patients who were divided into two groups based on T (stage and depth of myometrial invasion) and N (lymph node status) parameters. All patients had histologic evidence of well/moderately-differentiated adenocarcinoma (G1-G2). The low-risk group consisted of stage I patients with superficial myometrial involvement and no lymphadenopathy, while the high-risk group consisted of the patients with deep myometrial invasion and/or stage II and/or positive lymph nodes. All patients were operated on-i.e., total abdominal hysterectomy with vaginal cuff, bilateral salpingo-oophorectomy and pelvic lymphadenectomy. The patients were followed-up for 36 months at least. On the basis of CT findings, 85 patients were included in the low-risk group, but 11 misstaged cases were found at surgery in which lymphadenectomy never changed the factor risk. Only four relapses (4.7%) were observed in this group. Forty patients were included in the high-risk group: CT misstaged 20 cases and 12 relapses (30%) were observed. This study demonstrates the clinical value of CT in the assessment of radiologic risk factors in stage I endometrial carcinoma; CT findings can be used as guidelines for different treatments.

Entities:  

Mesh:

Year:  1997        PMID: 9251740

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  4 in total

1.  Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus.

Authors:  Yulia Lakhman; Seth S Katz; Debra A Goldman; Derya Yakar; Hebert A Vargas; Ramon E Sosa; Maura Miccò; Robert A Soslow; Hedvig Hricak; Nadeem R Abu-Rustum; Evis Sala
Journal:  Ann Surg Oncol       Date:  2015-02-10       Impact factor: 5.344

2.  Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.

Authors:  Nadim Bou Zgheib; Douglas C Marchion; Stephen H Bush; Patricia L Judson; Robert M Wenham; Sachin M Apte; Johnathan M Lancaster; Jesus Gonzalez-Bosquet
Journal:  Oncol Lett       Date:  2015-11-06       Impact factor: 2.967

3.  Pilot Study to Establish a Novel Five-Gene Biomarker Panel for Predicting Lymph Node Metastasis in Patients With Early Stage Endometrial Cancer.

Authors:  Chia-Yen Huang; Kuang-Wen Liao; Chih-Hung Chou; Sirjana Shrestha; Chi-Dung Yang; Men-Yee Chiew; Hsin-Tzu Huang; Hsiao-Chin Hong; Shih-Hung Huang; Tzu-Hao Chang; Hsien-Da Huang
Journal:  Front Oncol       Date:  2020-01-21       Impact factor: 6.244

Review 4.  A systematic review of tests for lymph node status in primary endometrial cancer.

Authors:  Tara J Selman; Christopher H Mann; Javier Zamora; Khalid S Khan
Journal:  BMC Womens Health       Date:  2008-05-05       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.